EdgeMarketInstruments › PRTA

PRTA — PROTHENA CORP PUBLIC LTD CO

US Healthcare Pharma & biotech equity mkt cap 463.6M
9.45 +4.65% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 7.91 · high 11.51

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.

Performance

1 day+4.65%
1 week+6.66%
1 month+10.79%
3 months+0.43%
6 months+4.77%
Year to date+2.72%
1 year+10.92%
3 years-84.03%
5 years-83.83%

Technicals

RSI 1470.1
vs 50-day avg+5.76%
vs 200-day avg-0.89%
Volatility 1y47.9%
Max drawdown 1y-31.28%
Avg volume 30d501.7K
Daily bars held2,674
History from2016-01-04

Measured signals that fired on PRTA

datesignal measured base rate
2026-06-09Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group
2026-04-28Breakout to a 52-week high
price
-1.00% over 21 days · t = -8.58 · n = 24,386
statistically distinguishable from its control group
2026-04-23Equal highs taken out
structure
-0.70% over 21 days · t = -8.28 · n = 68,636
statistically distinguishable from its control group
2026-03-11Short volume far above its own normal
short
-0.76% over 21 days · t = -2.79 · n = 5,897
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-08-20SCULLY WILLIAM P
10% owner
Open-market purchase50.0K8.79439.4K
2026-08-18SCULLY WILLIAM P
10% owner
Gift627.6K0.000
2026-08-17SCULLY WILLIAM P
10% owner
Gift336.0K0.000
2026-08-10SCULLY WILLIAM P
10% owner
Gift251.6K0.000
2026-08-07SCULLY WILLIAM P
10% owner
Open-market purchase34.0K8.62293.1K
2026-08-07SCULLY WILLIAM P
10% owner
Open-market purchase3.5K8.6230.2K
2026-07-29Isaacs Michael John
General Counsel & Company Sec.
Open-market sale 10b5-1 plan8.4K8.4771.1K
2026-07-29Kingston Anne Evans
Chief Strategy Officer
Open-market sale 10b5-1 plan7.7K8.4764.9K
2026-07-28Kinney Gene G.
President and CEO
Disposition to issuer84.0K8.56719.0K
2026-07-28Smith Brandon S.
Chief Operating Officer
Disposition to issuer78.0K8.56667.7K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
FMR LLC73.4M7.6M
Rubric Capital Management LP48.6M5.0M
BlackRock, Inc.45.1M4.6M
STATE STREET CORP18.8M1.9M
D. E. Shaw & Co., Inc.17.1M1.8M
ADAR1 Capital Management, LLC15.4M1.6M
VANGUARD PORTFOLIO MANAGEMENT LLC14.1M1.4M
MORGAN STANLEY12.0M1.2M
Palo Alto Investors LP11.7M1.2M
TWO SIGMA INVESTMENTS, LP11.7M1.2M

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
SCHEDULE 13G/A2026-08-14on EDGAR ↗
42026-08-112026-08-10on EDGAR ↗
32026-08-112026-08-06on EDGAR ↗
42026-08-102026-08-07on EDGAR ↗
10-Q2026-08-062026-06-30on EDGAR ↗
8-K2026-08-062026-08-06on EDGAR ↗
SCHEDULE 13G/A2026-08-06on EDGAR ↗
42026-07-302026-07-28on EDGAR ↗

Short selling

Avg short volume, 90d65.4% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Ask the AI about PRTA

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open PRTA in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →